Sunshine Biopharma Inc (SBFM) Live Share Price, Invest From India

Sunshine Biopharma Inc Stock Performance

as on May 25, 2026 at 2:16 pm IST

Day's Low
Day's High
$0.44
Day's Price Range
$0.50
$0.48
8.33%
Downside
4.17%
Upside
52 Week's Low
52 Week's High
$0.28
52-Week Price Range
$2.43
$0.48
41.42%
Downside
406.25%
Upside

Sunshine Biopharma Inc share price movements today

Previous Close: $0.52
Open: $0.45
Volume: 11.5M
Day's Low - High: $0.44 - $0.50
52 Week Low - High: $0.28 - $2.43

Sunshine Biopharma Inc Historical Returns

1 Month Return: -51.87 %
3 Month Return: -60.87 %
1 Year Return: -66.58 %
3 Year Return: -99.96 %
5 Year Return: 0 %

Sunshine Biopharma Inc Stock Fundamentals & Key Indicators

Check Sunshine Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4M

EPS (TTM)

-0.63

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-4.2M

Revenue (TTM)

35.5M

Profit Margin

-17.02%

Return On Equity TTM

-27.32%

Sunshine Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sunshine Biopharma Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Sunshine Biopharma Inc	BUY	$2.4M	NA	NA	-17.02%	NA
United Therapeutics Corporation	BUY	$24.1B	NA	21.01	40.62%	NA
Viatris Inc	HOLD	$19.4B	9.83%	NA	-2.04%	2.92%
Haleon plc	BUY	$41.1B	NA	18.58	15.11%	0.76%
Zoetis Inc	BUY	$34.1B	-53.62%	13.33	28.04%	2.54%

See all

Stock Returns calculator for Sunshine Biopharma Inc Stock including INR - Dollar returns

The Sunshine Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Sunshine Biopharma Inc investment value today

Current value as on today

₹37,487

Returns

-₹62,513

(-62.51%)

Returns from Sunshine Biopharma Inc Stock

-₹66,667 (-66.67%)

Dollar Impact

₹4,154 (+4.15%)

Analyst Recommendation on Sunshine Biopharma Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Sunshine Biopharma Inc. Average target price of $5.6

Sunshine Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Sunshine Biopharma Inc.

What analysts predicted

91.43%UPSIDE

Target Price

$5.6

Current Price

$0.48

Analyzed by

7 Analysts

Target

$5.60

Sunshine Biopharma Inc target price $5.6, a slight upside of 91.43% compared to current price of $0.48. According to 7 analysts rating.

Indian Investors' Interest in Sunshine Biopharma Inc Stock

Investment in Sunshine Biopharma Inc Shares on INDmoney has grown by 12100.00% in the last 30 days, indicating increased investment activity.

Time period: April 26, 2026 to May 26, 2026

Change:12100.00% versus previous 30 day period

Search interest for Sunshine Biopharma Inc Stock has increased by 6639% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 26, 2026 to May 26, 2026

Change:6639% versus previous 30 day period

Sunshine Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	7	7	9	8	9	8	9	9	8	8
Gross Profit	2	2	2	2	3	2	3	3	3	2
Operating Income	-1	-1	-1	-1	-2	-1	0	0	-1	-1
EBITDA	0	-1	0	0	-	-1	-1	0	-	-1
Interest Expense	0	0	0	0	0	0	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	0	0	-2	-1	-1	-1	-1	-1
Income Tax Expense	0	0	0	0	-	0	0	0	-	0
Net Income	-1	-1	0	-1	-2	-1	-1	0	-2	-1
Net Profit Margin	-16.28%	-17.02%	-5.31%	-14.20%	-22.49%	-13.25%	-18.82%	-9.39%	-24.96%	-15.38%

Sunshine Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	0	0	0	0	4	24	34	36
Gross Profit	0	0	0	0	0	0	1	8	10	11
Operating Income	0	0	-1	0	0	-2	-8	-4	-5	-4
EBITDA	0	0	-1	0	-2	-12	-26	-3	-5	-4
Interest Expense	0	0	0	0	0	0	0	0	0	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	-1	-2	-1	-2	-12	-26	-4	-5	-5
Income Tax Expense	2	0	0	0	-1	0	0	0	0	0
Net Income	-3	-1	-2	-1	-2	-12	-26	-4	-5	-5
Net Profit Margin	0.00%	0.00%	-482.15%	-7860.85%	-3898.74%	-5444.41%	-615.44%	-18.70%	-14.72%	-16.46%

Sunshine Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Dec 2025	Mar 2026
Net Income	-1	0	-1	-2	-1	-1	-2	-1
Operating Cash Flow	-3	-4	-1	-3	-1	-1	-1	-2
Investing Cash Flow	0	0	0	-	0	0	-	0
Financing Cash Flow	5	0	1	2	0	3	0	0
Change in Cash	1	-5	0	-1	-1	2	0	-2

Sunshine Biopharma Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	-2	-1	-2	-12	-26	-4	-5	-5
Operating Cash Flow	0	0	0	0	-1	-5	-8	-12	-5
Investing Cash Flow	0	0	0	0	-14	-14	0	-2	0
Financing Cash Flow	0	0	0	1	2	39	3	9	4
Change in Cash	0	0	0	0	1	19	-5	-6	0

Global Institutional Holdings in Sunshine Biopharma Inc

Funds	Holdings
Strive Financial Group ,LLC	0%
Federation des caisses Desjardins du Quebec	0%
Two Sigma Investments LLC	0%
Connective Capital Management LLC	0%
TD Waterhouse Canada Inc	0%

See all

Insights on Sunshine Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -2.14M → -1.24M (in $), with an average increase of 72.1% per quarter
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation Common Stock has given 82.8% return, outperforming this stock by 182.8%
NO EFFECT
Against Peers
In the last 1 year, Viatris Inc. Common Stock has given 100.8% return, outperforming this stock by 167.4%
NEGATIVE IMPACT
Price Dip
In the last 1 month, SBFM stock has moved down by -51.9%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 9.41M → 8.08M (in $), with an average decrease of 7.3% per quarter

About Sunshine Biopharma Inc

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Organisation	Sunshine Biopharma Inc
Headquarters	333 Las Olas Way, Fort Lauderdale, FL, United States, 33301
Industry	Drug Manufacturers - Specialty & Generic
CEO	Dr. Steve N. Slilaty Ph.D.
E-voting on shares	Click here to vote

Key Management of Sunshine Biopharma Inc

Name	Title
Mr. Michel Roy	Chief Commercial Officer
Mr. Malek Chamoun	Chief Development Officer
Mr. Robert G. Ferreira	President of Sunshine Bio Investments Inc
Dr. Steve N. Slilaty Ph.D.	Chairman, President & CEO
Mr. Camille Sebaaly	CFO, Secretary & Director

FAQs

What is Sunshine Biopharma Inc share price today?

Sunshine Biopharma Inc share price today is $0.48 as on May 25, 2026 at 8:46 am IST at the close of the market. Sunshine Biopharma Inc share today touched a day high of $0.5 and a low of $0.44.

What is the 52 week high and 52 week low for Sunshine Biopharma Inc share?

Sunshine Biopharma Inc share touched a 52 week high of $2.43 on October 16, 2025 and a 52 week low of $0.28 on May 15, 2026. Sunshine Biopharma Inc stock price today i.e. May 25, 2026 at 8:46 am IST is closed at $0.48,which is 80.25% down from its 52 week high and 70.70% up from its 52 week low.

What is Sunshine Biopharma Inc's market capitalisation today?

Sunshine Biopharma Inc market capitalisation is $0.00T as on May 25, 2026 at 8:46 am IST.

How to invest in Sunshine Biopharma Inc Stock (SBFM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sunshine Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sunshine Biopharma Inc Shares that will get you 3.1250 shares as per Sunshine Biopharma Inc share price of $0.48 per share as on May 25, 2026 at 8:46 am IST.

What is the minimum amount required to buy Sunshine Biopharma Inc Stock (SBFM) from India?

Indian investors can start investing in Sunshine Biopharma Inc (SBFM) shares with as little as ₹95.69 or $1 (as of May 26, 2026 at 6:27 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.90 in Sunshine Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on May 26, 2026 at 6:27 pm IST). Based on Sunshine Biopharma Inc share’s latest price of $0.48 as on May 25, 2026 at 8:46 am IST, you will get 20.8333 shares of Sunshine Biopharma Inc. Learn more about fractional shares .